Status:
COMPLETED
Influence of Oxytocin on Approach-avoidance Tendencies to Social and Non-social Stimuli
Lead Sponsor:
KU Leuven
Conditions:
Basic Science
Eligibility:
MALE
18-35 years
Phase:
NA
Brief Summary
In this study, a randomized, placebo-controlled between-subject design is adopted to investigate the effect of a single-dose of intranasally administered OT on approach-avoidance related motivational ...
Detailed Description
The neuropeptide oxytocin (OT) plays an important role in a wide-range of complex social behaviors. Recently however, the 'social' specificity of OT's action has been challenged, considering several o...
Eligibility Criteria
Inclusion
- right-handed
- male
- age between 18 and 35
- Normal or adjusted-to-normal vision (with lenses only)
- Dutch as mother tongue
Exclusion
- female
- age below 18 or above 35
- neurological or psychiatric condition (e.g. epilepsy, stroke, concussion), (e.g. anxiety disorder, depression)
- use of psychotropic medication (e.g. anxiolytics, antidepressants)
Key Trial Info
Start Date :
December 15 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 30 2020
Estimated Enrollment :
64 Patients enrolled
Trial Details
Trial ID
NCT04443647
Start Date
December 15 2018
End Date
January 30 2020
Last Update
June 23 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
KU Leuven
Leuven, Belgium, 3000